BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21936877)

  • 1. The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death.
    Mertens B; Varcin M; Michotte Y; Sarre S
    Eur J Neurosci; 2011 Oct; 34(7):1141-8. PubMed ID: 21936877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration.
    Villar-Cheda B; Valenzuela R; Rodriguez-Perez AI; Guerra MJ; Labandeira-Garcia JL
    Neurobiol Aging; 2012 Jan; 33(1):204.e1-11. PubMed ID: 20888078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with L-DOPA.
    Dominguez-Meijide A; Villar-Cheda B; Garrido-Gil P; Sierrra-Paredes G; Guerra MJ; Labandeira-Garcia JL
    Neuropharmacology; 2014 Jan; 76 Pt A():156-68. PubMed ID: 23973568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system.
    Rodriguez-Perez AI; Valenzuela R; Villar-Cheda B; Guerra MJ; Labandeira-Garcia JL
    Brain; 2012 Jan; 135(Pt 1):124-38. PubMed ID: 22189567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxidative and nitrogen species in the nigrostriatal system following striatal 6-hydroxydopamine lesion in rats.
    Henze C; Earl C; Sautter J; Schmidt N; Themann C; Hartmann A; Oertel WH
    Brain Res; 2005 Aug; 1052(1):97-104. PubMed ID: 16005444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
    Lee EY; Lee JE; Park JH; Shin IC; Koh HC
    Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatum.
    Mertens B; Vanderheyden P; Michotte Y; Sarre S
    Neuropharmacology; 2010 Jun; 58(7):1038-44. PubMed ID: 20097214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
    Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
    J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
    Yuan H; Sarre S; Ebinger G; Michotte Y
    Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat.
    Stragier B; Sarre S; Vanderheyden P; Vauquelin G; Fournié-Zaluski MC; Ebinger G; Michotte Y
    J Neurochem; 2004 Sep; 90(5):1251-7. PubMed ID: 15312180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDI tripeptide of gamma1 laminin protects rat dopaminergic neurons from 6-OHDA induced toxicity.
    Väänänen AJ; Rauhala P; Tuominen RK; Liesi P
    J Neurosci Res; 2006 Aug; 84(3):655-65. PubMed ID: 16810683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats.
    Kim YK; Lim HH; Song YK; Lee HH; Lim S; Han SM; Kim CJ
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):133-8. PubMed ID: 15893426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension.
    Yu Y; Fukuda N; Yao EH; Matsumoto T; Kobayashi N; Suzuki R; Tahira Y; Ueno T; Matsumoto K
    Am J Hypertens; 2008 Jan; 21(1):72-7. PubMed ID: 18091747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease.
    Wu L; Tian YY; Shi JP; Xie W; Shi JQ; Lu J; Zhang YD
    Neurosci Lett; 2013 Aug; 548():50-5. PubMed ID: 23774475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
    Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
    Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.